Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

143 results about "Vascularizes" patented technology

Method for building hollow vascularized heart based on 3D biological printing technology and hollow vascularized heart

The invention provides a method for building a hollow vascularized heart based on the 3D biological printing technology and the hollow vascularized heart and relates to the technical field of tissue engineering and biology. The method includes: performing reverse modeling to build a heart three-dimensional grid model, importing the data of the heart three-dimensional grid model into a double-nozzle biological printing machine, and driving the nozzles of the printing machine to move according to a predesigned CAD digital model and selected forming parameters, wherein the nozzle 1 of the printing machine is loaded with sacrificial materials and used for printing a support framework, the nozzle 2 of the printing machine sprays biological ink to obtain building bodies, and the effective components of the biological ink comprise hydrogel, platelet-rich plasma, third-generation human umbilical vein endothelial cells and SD rat primary cardiomyocytes; crosslinking and cleaning the building bodies, and performing three-dimensional culture to form the hollow vascularized heart. The method has the advantages that the problem that a large-size hollow vascularized heart is hard in integrated printing, and the hollow vascularized heart built by the method is high in cell activity and has certain functions.
Owner:叶川 +2

Bionic artificial bone scaffold and preparation method thereof

The invention relates to a bionic artificial bone scaffold and a preparation method thereof. The method comprises the following steps: preparing material solutions A and B; utilizing an electrostatic spinning method to respectively prepare the material solutions A and B into a central channel layer and a peripheral column layer of a scaffold, wherein nanometer fibers in the central channel layer are in same spiral directions and the fibers in two adjacent nanometer fiber layers in the peripheral column layer are in opposite spiral directions; micro-level finely simulating a three-dimensional microenvironment of an osteon; hierarchically adding growth factors, supplying a differential inducing environment to seed cells BMSCs and constructing the bionic artificial bone scaffold with vascularizing tissues in the central channel layer and bone tissues in the peripheral column layer. The staggered orientation of the nanometer fibers in the scaffold can greatly enhance the structural stability; effective mechanic support is supplied to a bone defect part; the mutually connected network frame thereof is beneficial to cell permeation growth and blood vessel and nerve growth and also is convenient to transfer nutrient substances and metabolic wastes; the bionic artificial bone scaffold has ideal popularization and application values in the fields of biomedical materials and tissue engineering.
Owner:ARMY MEDICAL UNIV

Preparation method of biological scaffold material and SVF assistant adipose tissue

The invention discloses a preparation method and an application of a biological scaffold material and SVF assistant adipose tissue. Under an aseptic condition, the biological scaffold material, a stromal vascular fraction (SVF) prepared by digesting purified adipose granules with a medical-graded collagenase, and the purified adipose particles are evenly mixed according to a certain proportion to prepare an adipose graft for filling. The SVF is a mixture of adipose mesenchymal stem cells and various cells, is transplanted after being mixed with autogenous adipose particles, and can be continued to be developed into a mature adipose tissue in vivo; the biological scaffold material can provide a support for transplanted adipose, allows the transplanted tissue to be prone to revascularization, and improves the survival rate of the transplanted tissue; the transplanted tissue is suitable for being injected with a 16 G or 18 G needle, facilitates clinical application, and can be used for repairing of concave deformity (such as tempora and cheek concave), beautifying packing of faces and chests, soft tissue function reconstruction and the like; and especially in the beautifying packing, the prepared transplanted adipose tissue can promote shape recovery and prevent liquefactive necrosis.
Owner:广东佰鸿干细胞再生医学有限公司

Vascularized tumor microfluidic organ chip used for culture in vitro, and preparation method for vascularized tumor microfluidic organ chip

The invention provides a vascularized tumor microfluidic organ chip used for culture in vitro, and a preparation method for the vascularized tumor microfluidic organ chip. The chip comprises a PMMA module and a glass sheet, wherein the PMMA module is provided with three through holes which penetrate through the thickness direction of the PMMA module; the periphery of the upper surface of the glasssheet and the periphery of the lower surface of the PMMA module are bonded into a whole through a bonding layer, and the three through holes independently form a first cavity used for containing a tumor sphere, a second cavity used for storing culture solution, and a third cavity; in addition, the middle area of the lower surface of the PMMA module and the glass sheet form a hollow tissue cavity;and a static pressure difference generated by the culture solution with a liquid level height difference can accelerate a three-dimensional blood capillary network to be generated, and through co-culture of the three-dimensional blood capillary network and the tumor sphere, blood capillaries can be collected and can be constructed into three-dimensional vascularized tumor micro-tissues. The chipovercomes the defects of time consumption and high cost when the microfluidic organ chip is manufactured at present, the chip has a simple technology, and an application value is provided especially for researching in vitro vascularized tumor diseases.
Owner:SHANGHAI JIAO TONG UNIV

Method for constructing regenerated nerve vascularized bones, cartilages, joints or body surface organs

The invention relates to a method for constructing regenerated nerve vascularized bones, cartilages, joints or body surface organs by a prefabricated female die bracket. Firstly, the female die bracket of a defected tissue or organ is printed in a three-dimension manner by using a computer assisted design/manufacturing technology; then, a surface of a periosteum and/or perichondrium is formed in a body through an operation, the female die bracket is placed and fixedly sutured on a germinal layer of the autologous periosteum and/or perichondrium to form a closed space; after the bones, cartilages, joints or body surface organs whose male die shape corresponds to a female die are regenerated in the space constructed by the female die and the germinal layer of the surface of the periosteum and/or perichondrium, a newly regenerated tissue is taken out, the female die bracket is removed, and the tissue is transplanted to the position of the defected tissue or organ to reconstruct. The newly generated tissue or organ prepared through autologous prefabrication has rich new vessels and nerves, does not contain any exogenous materials participating in tissue regeneration, is high in safety, accurate in shape at the same time, and quite similar to the normal tissue or organ.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Vascularized tissue engineering bone and preparation method thereof

The invention relates to a vascularized tissue engineering bone and a preparation method thereof. The vascularized tissue engineering bone is composed of a support composed of poly-L-lysine (PLL) modified coralline hydroxyapatite (CHA) as well as a vascular endothelium dermatoblast patch and a bone formation cell patch which are sequentially wrapped at the inner layer of the support. According to the invention, an exogenous support obtained by virtue of the PLL modified CHA is beneficial to crawling ingrowth of blood vessels, and vascularization is realized finally, so that a precondition is provided for long term survival of cells in the tissue engineering bone, and organism immune rejection and inflammatory response are also reduced; adipose mesenchymal stem cells are selected for preparing a double cell patch, endothelial cells different in sources do not need to be added, cells are rich in resources and easy to separate and acquire, a trauma on a donor is minimal, ethical principles are not violated, and culture requirements are low. The vascularized tissue engineering bone provided by the invention is simple in preparation method and mild in preparation conditions, has good bone formation and vascularization properties, is consistent with in vivo application requirements, and has good application prospects as a novel vascularized tissue engineering bone.
Owner:NINGXIA MEDICAL UNIV

Generation of vascularized human heart tissue and uses thereof

The present invention relates to the generation of vascularized human heart tissue from human primordial Islet1-positive (ISL1+) progenitors, and more particularly the generation of vascularized human heart tissue from human primordial Islet1+ cardiovascular stem cells which are positive for markers ISL1+ / NKX2.5− / KDR−. One aspect of the invention relates to isolation of human ISL1+ primordial cells from human pluripotent cells, such as human ES cells or other human pluripotent stem cell sources, wherein the human ISL1+ primordial cells can differentiate into three different lineages; cardiomyocyte lineages, endothelial lineages and smooth muscle lineages. Another aspect relates to use and implantation of the human primordial ISL1+ progenitors into an animal model to generate human vascularized heart tissue, and more particularly, the production of an in vivo humanized model of vascular disease. One embodiment relates to the use of an in vivo humanized model of vascular disease as an assay, for example to assess drug toxicity and / or identify agents which increase and decrease coronary blood flow to the human vascularized heart tissue. Another embodiment relates to the therapeutic use of human primordial ISL1+ progenitors, for example, in one embodiment the invention provides methods for the treatment cardiovascular disorders and / or congenital heart disease in a subject comprising transplanting into subjects vascularized human heart tissue generated from human ISL1+ progenitors.
Owner:THE GENERAL HOSPITAL CORP

Hemostatic compressor for cardiology department

The invention relates to the technical field of medical device accessories, and in particular relates to a hemostatic compressor for the cardiology department. The hemostatic compressor for the cardiology department is simple in structure; compression treatment of the affected part of a patient is carried out by using a GelMA hydrogel dressing; the additional burden of a medical staff is reduced;wound surface vascularisation and epithelial regeneration are accelerated; the wound surface healing speed is increased; the infection rate is reduced; and the living quality of the patient is improved. The hemostatic compressor for the cardiology department comprises a sickbed, a reciprocating screw, a limiting rod and a GelMA hydrogel dressing patch; a left platform is arranged at the left end of the sickbed; the top of the left platform is fixedly connected with a first rodless cylinder; the first rodless cylinder is glidingly provided with a sliding block; the top of the sliding block is fixedly connected with a left bracket; the top of the left bracket is fixedly connected with a second rodless cylinder; the second rodless cylinder is glidingly provided with a movable block; a first cylinder is arranged at the bottom of the movable block; the output end of the first cylinder is provided with a box, which is hollow; the inner bottom of the box is fixedly connected with two sets ofsupport rods; and both the two sets of support rods are each provided with a first bearing.
Owner:THE AFFILIATED HOSPITAL OF QINGDAO UNIV

Method for preparing multilayer spiral urethral tissue engineering scaffold

The invention discloses a method for preparing a multilayer spiral urethral tissue engineering scaffold. A thermoplastic degradable polymer is used as a printing raw material, a rectangular strip embryoid body with hollow patterns by adopting a fused deposition type 3D printer, an embryoid body spiral tube is obtained by spirally curling, and after heat treatment and nesting, a double-layer scaffold consisting of an inner-layer embryoid body spiral tube and an outer-layer embryoid body spiral tube is obtained, one end of the double-layer scaffold is sewed by a polylactic acid suture, an endothelial cell sheet layer and a urothelial cell sheet layer which are transfected with vascular endothelial growth factors and fibroblast growth factors during culture and a smooth muscle cell sheet layer which is transfected with human platelet growth factors during culture are lined on the inner wall of the outer embryoid body spiral tube in sequence, extracellular matrix is filled, the other end of the double-layer scaffold is sewed, and the urethral tissue engineering scaffold can be obtained after thrombin is fixed. The scaffold prepared by the invention can keep a urethra smooth, is beneficial to healing the injured urethra tissue, realizes the vascularization of a urethra scaffold in time and can quickly realize the revascularization.
Owner:SOUTHEAST UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products